Local Leaders Convene in Boston to Share Industry Best Practices in…

On March 13th, industry leaders from the Boston area will convene with Big Data thought leaders at Knowledgent’s “The Business of Big Data: Maximizing the Value of Information” event, hosted in the…

(PRWeb February 25, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10466948.htm


Which Drugs Have the Most Patents?

This chart shows the pharmaceutical drugs with the most patents still in force. The drugs with the most active patents are COMBIVENT RESPIMAT, KALETRA, ADVAIR HFA,FLOVENT HFA, VIVITROL, THALOMID, VYVANSE, REVLIMID, VENTOLIN HFA, andCHILDREN’S ALLEGRA ALLERGY. For more infographics, see the DrugPatentWatch Pharmaceutical Innovation Infographics. Do you have a response to this infographic? Respond in the comments section below.


SHL to Invest 40 Million USD in 2013 to Significantly Expand…

SHL announced plans to invest 40 million USD in 2013 to significantly expand production facilities to allow for further capacity.(PRWeb February 25, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10458242.htm


Marrone Bio Innovations Submits New Bioherbicide for EPA Registration

Product provides post-emergent weed control with low risk of resistance. Will be registered for agricultural, non-crop and consumer markets.(PRWeb February 25, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10461667.htm


University of Chicago Medicine is the First in Illinois to Adopt…

University ophthalmologists Seenu M. Hariprasad, MD, Michael Saidel, MD, and Susan Ksiazek, MD use 3D Hi-Def system for microsurgery.(PRWeb February 25, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10455776.htm


FibeRio® Technology Corporation Announces Strategic Investment…

FibeRio announces a $13M capital raise led by SABIC Ventures B.V., Saudi Basic Industries Corporation’s corporate venture capital arm, and Aster Capital Partners, sponsored by Solvay, Schneider…

(PRWeb February 25, 2013)

Read the full story at http://www.prweb.com/releases/2013/2/prweb10456776.htm